To study whether CD44 might mediate TTR macrophage-induced resistance formation, we first treated two melanoma cell lines exhibiting high CD44 expression with CD44 blocking antibodies33 in the presence or absence of MEKi. This evidence concerns the gene CD44 and melanoma.